Calypte Biomedical Corp (CBMC) financial statements (2022 and earlier)
5000 HOPYARD ROAD, SUITE 480
PLEASANTON, CA 94588
|State of Incorp.||DE|
|Fiscal Year End||December 31|
|SIC||3826 - Laboratory Analytical Instruments (benchmarking)|
|More info||Complete financial analysis Financial benchmarking|
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.